39346576|t|Inflammatory Manifestations Associated With Gut Dysbiosis in Alzheimer's Disease.
39346576|a|Recent studies strongly suggest that gut microbiome can influence brain functions and contribute to the development of Alzheimer's disease (AD). However, reported changes in the gut microbiomes in AD patients from different countries are not similar, and more research is needed to reveal the relationships between human microbiomes and AD in diverse ethnic populations. There is also an assumption that microbiome-associated peripheral inflammation might drive the development of sporadic AD. This cross-sectional study is aimed at analyzing the gut microbial profile and exploring potential associations with blood cytokines and some clinical parameters among individuals diagnosed with Alzheimer's in Kazakhstan. Consistent with previous studies, we have found that the microbial landscape in AD reveals specific alterations in the gut microbiome. Specifically, the AD patient group showed a decreased Firmicutes/Bacteroidetes ratio. The differential abundance analysis highlighted a dysbiosis in the gut microbiota of AD patients, marked by a reduced presence of Bifidobacterium, particularly B. breve. In our study, AD patients' altered gut microbiota composition notably features an increased presence of Pseudomonadota like Phyllobacterium and inflammatory bacteria such as Synergistetes and the Christensenellaceae family. The metabolic profiling of the AD microbiome reveals a predominant presence of pathways related to sugar, carrier molecules, tetrapyrrole, pyrimidine biosynthesis, and nucleic acid processing. This analysis also highlighted a marked reduction in SCFA, carbohydrate, polysaccharide, polyamine, and myo-inositol degradation pathways. The increases in the proinflammatory cytokines IL-1a, IL-8, IL-17A, IL-12p40, TNF-beta, MCP-1, IL-2, and IL-12p70 and the anti-inflammatory cytokines IL-10 and IL-13 were observed in AD patients. Key variables driving the separation of AD and controls include inflammatory markers (IL-1a and IL-8), growth factors (EGF), lipids (LDL), BMI, and gut microbes, like genus Tyzzerella and Turicibacter and species Parabacteroides distasonis and Bacteroides eggerthii. We have also demonstrated that almost all cytokines strongly correlate with serum adiponectin levels and specific microbial taxa in AD patients. Thus, our findings identify potential microbial and inflammatory signatures in an ethnically distinct cohort of AD patients. These could serve as AD biomarkers and microbiota-based therapeutic targets for treating AD.
39346576	0	27	Inflammatory Manifestations	Disease	MESH:D007249
39346576	44	57	Gut Dysbiosis	Disease	MESH:D064806
39346576	61	80	Alzheimer's Disease	Disease	MESH:D000544
39346576	201	220	Alzheimer's disease	Disease	MESH:D000544
39346576	222	224	AD	Disease	MESH:D000544
39346576	279	281	AD	Disease	MESH:D000544
39346576	282	290	patients	Species	9606
39346576	397	402	human	Species	9606
39346576	419	421	AD	Disease	MESH:D000544
39346576	519	531	inflammation	Disease	MESH:D007249
39346576	572	574	AD	Disease	MESH:D000544
39346576	771	782	Alzheimer's	Disease	MESH:D000544
39346576	878	880	AD	Disease	MESH:D000544
39346576	951	953	AD	Disease	MESH:D000544
39346576	954	961	patient	Species	9606
39346576	1104	1106	AD	Disease	MESH:D000544
39346576	1107	1115	patients	Species	9606
39346576	1149	1164	Bifidobacterium	Species	1678
39346576	1203	1205	AD	Disease	MESH:D000544
39346576	1206	1214	patients	Species	9606
39346576	1333	1354	inflammatory bacteria	Disease	MESH:C000719206
39346576	1444	1446	AD	Disease	MESH:D000544
39346576	1512	1517	sugar	Chemical	MESH:D000073893
39346576	1538	1550	tetrapyrrole	Chemical	MESH:D045725
39346576	1552	1562	pyrimidine	Chemical	MESH:C030986
39346576	1659	1663	SCFA	Chemical	MESH:D005232
39346576	1665	1677	carbohydrate	Chemical	MESH:D002241
39346576	1679	1693	polysaccharide	Chemical	MESH:D011134
39346576	1695	1704	polyamine	Chemical	MESH:D011073
39346576	1710	1722	myo-inositol	Chemical	MESH:D007294
39346576	1766	1781	proinflammatory	Disease	
39346576	1792	1797	IL-1a	Gene	3552
39346576	1799	1803	IL-8	Gene	3576
39346576	1805	1811	IL-17A	Gene	3605
39346576	1816	1821	12p40	Chromosome	12
39346576	1823	1831	TNF-beta	Gene	4049
39346576	1833	1838	MCP-1	Gene	6347
39346576	1840	1844	IL-2	Gene	3558
39346576	1853	1858	12p70	Chromosome	12
39346576	1872	1884	inflammatory	Disease	MESH:D007249
39346576	1895	1900	IL-10	Gene	3586
39346576	1905	1910	IL-13	Gene	3596
39346576	1928	1930	AD	Disease	MESH:D000544
39346576	1931	1939	patients	Species	9606
39346576	1981	1983	AD	Disease	MESH:D000544
39346576	2005	2017	inflammatory	Disease	MESH:D007249
39346576	2027	2032	IL-1a	Gene	3552
39346576	2037	2041	IL-8	Gene	3576
39346576	2060	2063	EGF	Gene	1950
39346576	2066	2072	lipids	Chemical	MESH:D008055
39346576	2114	2124	Tyzzerella	Species	1506577
39346576	2129	2141	Turicibacter	Species	191303
39346576	2154	2180	Parabacteroides distasonis	Species	823
39346576	2185	2206	Bacteroides eggerthii	Species	28111
39346576	2290	2301	adiponectin	Gene	9370
39346576	2340	2342	AD	Disease	MESH:D000544
39346576	2343	2351	patients	Species	9606
39346576	2405	2417	inflammatory	Disease	MESH:D007249
39346576	2465	2467	AD	Disease	MESH:D000544
39346576	2468	2476	patients	Species	9606
39346576	2499	2501	AD	Disease	MESH:D000544
39346576	2567	2569	AD	Disease	MESH:D000544
39346576	Association	MESH:D007294	MESH:D000544
39346576	Negative_Correlation	MESH:D007249	3586
39346576	Negative_Correlation	MESH:D007249	3596
39346576	Association	MESH:D000544	3586
39346576	Association	MESH:D000544	6347
39346576	Association	MESH:D000544	4049
39346576	Association	MESH:D000073893	MESH:D000544
39346576	Association	MESH:D011073	MESH:D000544
39346576	Association	MESH:D000544	3558
39346576	Association	MESH:D000544	3596
39346576	Association	MESH:D045725	MESH:D000544
39346576	Association	MESH:C030986	MESH:D000544
39346576	Association	MESH:D000544	3605

